topiramate - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
APO-TOPIRAMATE topiramate 100 mg tablet blister pack AUST R: 124731 Active ingredients: topiramate Dosage form: Tablet, film coated Sponsor: Arrotex Pharmaceuticals Pty Ltd Phone: 1800 195 055	From 20 Dec 2024 to 07 Feb 2025	Shortage status: Anticipated Availability: Available Reason: Manufacturing Management action: Alternative generic products are available.
APO-TOPIRAMATE topiramate 200 mg tablet blister pack AUST R: 124732 Active ingredients: topiramate Dosage form: Tablet, film coated Sponsor: Arrotex Pharmaceuticals Pty Ltd Phone: 1800 195 055	From 20 Dec 2024 to 07 Mar 2025	Shortage status: Anticipated Availability: Available Reason: Manufacturing Management action: Alternative generic products are available.
APO-TOPIRAMATE topiramate 25 mg tablet blister pack AUST R: 124729 Active ingredients: topiramate Dosage form: Tablet, film coated Sponsor: Arrotex Pharmaceuticals Pty Ltd Phone: 1800 195 055	From 27 Dec 2024 to 24 Jan 2025	Shortage status: Anticipated Availability: Available Reason: Manufacturing Management action: The sponsor is working to expedite the next shipment. Alternative generic products are available.
APO-TOPIRAMATE topiramate 50 mg tablet blister pack AUST R: 124730 Active ingredients: topiramate Dosage form: Tablet, film coated Sponsor: Arrotex Pharmaceuticals Pty Ltd Phone: 1800 195 055	From 27 Dec 2024 to 24 Jan 2025	Shortage status: Anticipated Availability: Available Reason: Manufacturing Management action: The sponsor is working to expedite the next shipment. Alternative generic products are available.